FREY News and Press, FREYR Battery From 12/20/23

2023-12-20 16:04:27 ET Shares of electric car stocks Freyr Battery (NYSE: FREY) , Lucid Group (NASDAQ: LCID) , and Fisker (NYSE: FSR) tumbled in afternoon trading Wednesday, stung by The Wall Street Journal 's report out this morning detailing the financial diffi...

2023-12-20 08:36:29 ET Losers: Bluebird bio BLUE -52% on pricing of $125 million stock offering . Jin Medical International Ltd ( ZJYL ) -14% . Argen X SE ( ARGX ) -25% reports topline results from address study of Efgartigimod SC in Pemphigus . ...

FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, announced today that the U.S. Department of Energy (“DOE”) has invited the Company to submit the Part II loan application under ...

FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, announced today that the Company has received the required votes to approve all proposals at its Extraordinary General Meeting (“EGM&#x...

2023-12-15 13:00:21 ET More on Industrial Select Sector SPDR ETF XLI: The Forgotten Industrial Sector ETF Just Hit A New All-Time High XLI: Diversified Cyclicals Looking Better On Valuation, Bullish Seasonal Tailwinds (Rating Upgrade) Industrials saw the largest pace...

2023-12-12 08:39:32 ET Losers: Achieve Life Sciences ( ACHV ) -24% announces participation at upcoming investor conferences. Clearmind Medicine CMND -13% files for $50M mixed shelf . Oracle Corp. ORCL -10% after Q2 earnings release . Acurx Pharmaceu...

FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, has announced that two leading independent proxy advisory firms, Glass Lewis and Institutional Shareholder Services (“ISS”), rec...

2023-12-08 15:00:12 ET More on the markets S&P 500: New All-Time Highs Before A Major Sell-Off S&P 500 Forecast 2024: Muddling Through Only Thing That Matters Is Price; Nasdaq Has Further To Go - Cestrian Capital Research Money market funds attract mo...

2023-12-04 08:29:16 ET EyePoint Pharmaceuticals  ( EYPT ) +393% Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMD Achieving All Primary and Secondary Endpoints Alterity Therapeutics  ( ATHE ) +201% jumps after promising data ...

2023-12-01 12:06:22 ET Summary The Customer Qualification Plant was delayed and the timeline to complete commissioning has been pushed back beyond 4Q23 due to engineering and scaling challenges. Scaling the 24M platform has proven to be more challenging and time-consuming than exp...